Hershey's Recipe Fix Won’t Save the Bottom Line—Costs Still Threaten Earnings

The core issue here is a clash between cost-cutting and brand trust, and it was sparked by a family member who knows the brand's legacy better than anyone. Brad Reese, the grandson of H.B. Reese who invented the Peanut Butter Cup, publicly criticized Hershey for quietly replacing real chocolate with cheaper compound coatings in a small part of the Reese's line. His warning, delivered in a Valentine's Day letter posted on LinkedIn, struck at the heart of the brand's promise: "How does The Hershey Co. continue to position Reese's as its flagship brand, a symbol of trust, quality and leadership, while quietly replacing the very ingredients (Milk Chocolate + Peanut Butter) that built Reese's trust in the first place?" The products affected are a sliver-less than 3% of Reese's overall products, like mini Easter eggs and some foil-wrapped candies-but they are the ones that carry the brand's name.

This ingredient shift was a direct response to pressure from high cocoa prices, a persistent cost headwind for the entire industry. Yet, the timing of this controversy is what makes it a major distraction. It erupted just as Hershey was reporting a massive 60% nosedive in profits for 2025, with operating costs cited as the primary culprit. The tension is stark: the company is under intense financial pressure to cut costs, but it is also facing a crisis of confidence from the family that built its most iconic brand. In other words, the very strategy meant to protect the bottom line-using cheaper coatings-threatened the brand equity that drives long-term sales and pricing power. For a company already grappling with a steep profit decline, this is a costly distraction that forces it to defend its core identity just as it needs to focus on stabilizing its finances.

The Fix: What's Changing and What's Not

The company's response is a clear retreat on the specific products that sparked the firestorm. Hershey has committed to switching a small portion of its Reese's and Hershey's products back to their classic milk chocolate and dark chocolate recipes by 2027. This includes items like mini Easter eggs and some foil-wrapped candies that had been coated with cheaper chocolate compound. The change is a direct answer to the criticism, though it comes with a long lead time-consumers won't see the new versions until next year.

Crucially, the fix does not touch the brand's most important products. The company has repeatedly stated that the core recipes for our Hershey's chocolate bars and Reese's peanut butter cups have not changed. This is the product quality that drives sales and brand loyalty. The controversy was about a sliver of the portfolio, not the flagship. By preserving the classic Peanut Butter Cup, Hershey is protecting the asset that matters most.

The company is also using this moment to signal a broader, more expensive investment in its product line. Alongside the recipe tweaks, Hershey announced it will increase its research and development funding by 25 per cent next year. This capital will fund talent and technology to enhance the Kit Kat recipe for a "creamier" taste and transition the entire sweets portfolio to natural colors. This is a significant bet on product innovation and modernization, moving beyond just fixing a single ingredient issue.

Viewed another way, this is a classic "kiss the baby" move. Hershey is acknowledging the family's warning and the consumer backlash by reverting a few minor products, while simultaneously doubling down on R&D for its core brands. The goal is to rebuild trust on the edges while investing in the center. The real test will be whether this spending pays off in sales and brand health, or if it simply adds cost to a business already struggling with a steep profit decline.

The Real Business: Sales, Costs, and the Bottom Line

The recipe fix is a low-cost brand sentiment gesture. The real business is a different story. Despite the massive 60% nosedive in profits for 2025, the core engine of Hershey's cash flow remains strong. The company's most iconic product, Reese's Peanut Butter Cups, is still a powerhouse. Recent sales data shows robust performance with North American Confectionery net sales growing 2.1% year-over-year last quarter. This isn't a minor product line; it's the heart of the business, generating over $1.2 billion in U.S. retail sales last year and holding a commanding 28% share of the chocolate peanut butter segment.

This sustained demand supports the stock. Even with the profit decline, Hershey's shares have climbed 8% year-to-date. That rally reflects investor confidence in the brand's enduring appeal, not the ingredient changes. The problem isn't the cost of classic chocolate for a few minor items. It's the persistent, overwhelming pressure from operating costs across the entire business.

Viewed another way, the recipe fix is a tactical move, not a strategic pivot. It addresses a specific, manageable issue-a sliver of the portfolio-while the company grapples with a much larger financial challenge. The fix costs little in terms of materials, but the underlying cost pressures are massive and systemic. As one analyst notes, operating costs remain a significant problem that shows no sign of improving soon. The company's own risk disclosures acknowledge that if it cannot offset rising raw material and energy costs, financial performance could be negatively impacted.

The bottom line is that this controversy distracts from the real work. Hershey needs to manage costs across its entire operation, not just on a few foil-wrapped candies. The stock's rise shows the market is betting on the brand's resilience, but the profit decline is a clear warning. The recipe change is a small, symbolic step to protect brand trust. The real battle for the bottom line is still ahead.

What to Watch: Catalysts and Risks

The recipe fix is a slow-burn catalyst. The changes Hershey promised for 2027 will take time to roll out. The real test is whether switching back to classic milk and dark chocolate for those minor products-like mini Easter eggs-helps stabilize brand perception for that sliver of the portfolio. It's a low-cost move to quiet a specific fire, but the market will be watching to see if it has any tangible effect on sales or sentiment for those items. The bigger risk, however, is that this distraction delays or diverts focus from the real cost problem.

The bottom line is still the bottom line. The massive 60% nosedive in profits for 2025 was driven by operating costs, and that pressure shows no sign of easing. The company's own risk disclosures warn that if it cannot offset rising raw material and energy costs, financial performance could be negatively impacted. For all the talk of brand consistency, the real driver of earnings is cost management. The stock's rally reflects confidence in the brand, but the profit decline is a clear warning. The company must find a way to reverse that trend, or the recipe changes will be a footnote in a story of financial struggle.

Then there's the R&D bet. Hershey plans to increase its research and development funding by 25 per cent next year. This capital will fund talent and technology to enhance the Kit Kat recipe and transition the entire sweets portfolio to natural colors. The goal is to boost sales beyond the core Reese's brand. The risk is that this spending adds cost to a business already under pressure, without delivering a clear return. The payoff will be in tangible product innovations that consumers love and are willing to pay for. If these new flavors and natural ingredients resonate, they could diversify the revenue stream. If not, it's just another expense on an already heavy ledger.

The setup is clear. Hershey is making a symbolic gesture on the edges of its product line while the real battle for the bottom line rages in its cost center. The market will be watching for two things: first, if the 2027 recipe changes are implemented smoothly and help protect brand trust; second, and more importantly, whether the company can manage its operating costs to reverse the steep profit decline. The R&D spending is a longer-term play that could pay off, but it must not come at the expense of fixing the immediate financial leak.